(Q35554870)

8 August 2017

Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome (English)

1 reference

antiphospholipid syndrome

8 August 2017

1 reference

1 reference

9

Shoenfeld Y

1 reference

8 August 2017

4

Blank M

1 reference

8 August 2017

1

Krause I

1 reference

8 August 2017

8

Chapman J

1 reference

8 August 2017

Lev S

2

1 reference

8 August 2017

Fraser A

3

1 reference

8 August 2017

Lorber M

5

1 reference

8 August 2017

Stojanovich L

6

1 reference

8 August 2017

Rovensky J

7

1 reference

8 August 2017

language of work or name

English

0 references

publication date

18 March 2005

1 reference

Annals of the Rheumatic Diseases

8 August 2017

1 reference

8 August 2017

64

1 reference

8 August 2017

10

1 reference

8 August 2017

1490-1493

1 reference

Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Features associated with epilepsy in the antiphospholipid syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Mitral valve vegetation and cerebral emboli in a primary antiphospholipid syndrome patient who had hepatitis C virus infection: report of a case and review of the literature.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Migraine, memory loss, and "multiple sclerosis ". Neurological features of the antiphospholipid (Hughes') syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Cardiac valvulopathy in the antiphospholipid syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Recent advances in antiphospholipid antibody-related valvulopathies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

The "primary" antiphospholipid syndrome: major clinical and serological features.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Valvular heart disease in the primary antiphospholipid syndrome

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Prevalence of anticardiolipin antibody in isolated mitral or aortic regurgitation, or both, and possible relation to cerebral ischemic events

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Systemic antiphospholipid syndrome.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Central nervous system involvement in the antiphospholipid (Hughes) syndrome

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1755247

The antiphospholipid story

26 September 2018

1 reference

12 December 2020

The anticardiolipin syndrome

1 reference

12 December 2020

High Prevalence of Significant Heart Valve Lesions in Patients with the 'Primary' Antiphospholipid Syndrome

1 reference

12 December 2020

Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients

1 reference

12 December 2020

Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings

1 reference

12 December 2020

Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves

1 reference

12 December 2020

Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease

1 reference

12 December 2020

Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome

1 reference

12 December 2020

Classification criteria for antiphospholipid syndrome: the case for cardiac valvular disease

1 reference

12 December 2020

Migraine and stroke in young women

1 reference

12 December 2020

The antiphospholipid syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.2004.032813

1 reference

8 August 2017

1 reference

8 August 2017

1 reference